News and Trends 8 Jan 2016
Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists
Founded in just 2013 by German Proteros and the US Atlas Ventures, Rodin Therapeutics is working epigenetics into discovery of…
Neurological disorders
- Latest Posts
News and Trends 6 Jan 2016
Growing Mini-Brains in Labs to Better Understand Neurological Disease
Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological…
News and Trends 22 Dec 2015
Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing
Mimetas from Leiden (NL) has now been financed to develop an Organ-on-Chip (tissue model) to specifically test Neurotoxicity, as a…
News and Trends 15 Dec 2015
Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials
Probiodrug's phase I tolerability and efficacy trial for Alzheimer's didn't quite go as planned, although results are in and it…
ADVERTISEMENT
News and Trends 7 Dec 2015
Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons
Relatives of the Jellyfish, researchers at the University of Geneva (Switzerland) have now proven the regenerative abilities of Hydra involved…
News and Trends 4 Dec 2015
Black Friday Ruin as TWO Biotechs Fail in Phase III Trials
A shocking Black Friday for these two Biotechs: Both CytoTools (Germany) and MedDay (France) phase III trials in chronic disease…
News and Trends 30 Nov 2015
Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal
Heptares Therapeutics from the UK has landed Pfizer in a huge potential $1.9Bn deal for their G-protein receptor platform. Heptares…
News and Trends 26 Nov 2015
The UK-Israeli €378M Small-Molecule Offensive Against Migraines
The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up on novel drug therapies targeting…
News and Trends 24 Nov 2015
2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?
Since both Alzheimer's Disease and Parkinson's combined affect up to 50 million people worldwide, it is no wonder this new…
News and Trends 17 Nov 2015
Epigenetics Drug Discovery has a New Champion!
Last week at BIO-Europe 2015 in Munich, I had the opportunity to meet Torsten Hoffmann, CSO of Proteros who told…
News and Trends 16 Nov 2015
Swissmedic Approves Zambon and Newron Therapy against Parkinson’s
Italian Pharma Newron and its partner Zambon (from Milan) have been granted a license by Swissmedic (the regulatory agency in Switzerland)…
News and Trends 26 Oct 2015
Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!
The fight against Alzheimer's with the World Health Organization and the G8 Dementia Summit rallies a collective of biotech industry…
News and Trends 15 Oct 2015
Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University College London's Institute for Neurology…
News and Trends 15 Oct 2015
Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease
Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts for their discovery program. Now…
News and Trends 14 Oct 2015
High-Risk Infant Cancer: Nature publishes on a New and Reliable Biomarker from Cologne
New Oncology from Cologne (Germany) is a biotech which today published a paper in Nature on tumor-profile recognition of cancer of…
News and Trends 9 Oct 2015
TauRX, the leading Alzheimer-focused Biotech, earns funding after Phase II breakthrough
The Tau protein has already been implicated in the onset of Alzheimer's, with many biotechs on the hunt for a…
ADVERTISEMENT
News and Trends 1 Oct 2015
Asceneuron’s latest stab at the Alzheimer’s challenge with Sofinnova
Paris based Sofinnova continues to invest in the Alzheimer's fight, with a €27.5M pot given to Swiss Asceneuron (originally a…
News and Trends 28 Sep 2015
New Smart Collaboration of Nestlé and AC Immune Against Alzheimer’s disease
Nestlé Institute of Health Sciences (NIHS) is teaming up with the Swiss AC Immune to develop a new minimally invasive…
News and Trends 22 Sep 2015
UniQure’s cure for rare Lysosomal disease ready for phase III trial
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease.…
News and Trends 17 Jul 2015
AC Immune receives Milestone Payment for Alzheimer Antibody
AC Immune received a first milestone payment from Roche’s subsidiary Genentech. The latter picked up a potential Alzheimer’s drug worth…
